Dr. Christopher Scott Nance, MD

Dr. Nance practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Nance's NPI, 1649370065, was assigned on September 25, 2006. Dr. Nance holds Iowa license MD-43384.

Dr. Nance's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Nance's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Nance is also affiliated with MercyOne Des Moines Medical Center. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Nance to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nance practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Nance's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Nance's licenses on file in 2 states: Iowa and West Virginia.

CMS data shows 507 Medicare services from Dr. Nance across 13 procedure codes in 2024, for 272 Medicare patients. Medicare paid $27,227 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 272 Medicare patients who saw Dr. Nance in 2024. The largest group is 65 to 74, with 126 patients. 69% of them have high cholesterol, and 68% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nance's median patient age at 71, with 45% women.

In 2024, Dr. Nance wrote 1,109 Medicare Part D claims for 171 patients. 89% of them were for generic drugs. CMS names the drug for 1,007 of them, across 27 drugs with 11 or more claims each, at $2,557,004 in total drug cost. In 2023, CMS named 700 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Nance for performance year 2024, reported as part of a group. Dr. Nance accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Nance, published from 2017 to 2024. Dr. Nance has published most often in Muscle Nerve. Dr. Nance's most frequent co-authors are Christopher L. Groth, MD, Laurie Gutmann, MD and Ludwig Gutmann, MD.

CMS Open Payments shows 1 general payment to Dr. Nance from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $79.